Sinsin Pharmaceutical Co Ltd banner
S

Sinsin Pharmaceutical Co Ltd
KOSDAQ:002800

Watchlist Manager
Sinsin Pharmaceutical Co Ltd
KOSDAQ:002800
Watchlist
Price: 4 370 KRW -1.69% Market Closed
Market Cap: ₩66.3B

Wall St Price Targets

Price Targets Summary
Sinsin Pharmaceutical Co Ltd

There are no price targets for Sinsin Pharmaceutical Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Sinsin Pharmaceutical Co Ltd Competitors:
Price Targets
IMRX
Immuneering Corp
243% Upside

Revenue
Forecast

8% / Year
Past Growth
-7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
8% / Year
Past Growth
-7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 9 years is -7%.

Gross Profit
Forecast

10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Sinsin Pharmaceutical Co Ltd

Operating Income
Forecast

18% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
18% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 11 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 9 years is -6%.

Pre-Tax Income
Forecast

20% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
20% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 11 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 9 years is -6%.

Net Income
Forecast

21% / Year
Past Growth
-8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
21% / Year
Past Growth
-8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 11 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 9 years is -8%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Sinsin Pharmaceutical Co Ltd's stock price target?
Not Available

Sinsin Pharmaceutical Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Sinsin Pharmaceutical Co Ltd?
Projected CAGR
-7%

Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 9 years is -7%.

What is the Operating Income forecast for Sinsin Pharmaceutical Co Ltd?
Projected CAGR
-6%

Over the last 11 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 9 years is -6%.

What is the Pre-Tax Income forecast for Sinsin Pharmaceutical Co Ltd?
Projected CAGR
-6%

Over the last 11 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 9 years is -6%.

What is the Net Income forecast for Sinsin Pharmaceutical Co Ltd?
Projected CAGR
-8%

Over the last 11 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 9 years is -8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett